Ocular Therapeutix, Inc. (OCUL)

9.05 -0.11 (-1.20%) USD  |  NASDAQ  |  Feb 12, 16:00
9.18 +0.13 (+1.44%) After-Hours: 18:28
More

Ocular Therapeutix EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for OCUL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Boston Scientific Corp. Upgrade
Alnylam Pharmaceuticals, Inc. --
Vertex Pharmaceuticals, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Krystal Biotech, Inc. Upgrade